ATE214930T1 - Antibakterielles mittel zur oralen verabreichung - Google Patents
Antibakterielles mittel zur oralen verabreichungInfo
- Publication number
- ATE214930T1 ATE214930T1 AT96933635T AT96933635T ATE214930T1 AT E214930 T1 ATE214930 T1 AT E214930T1 AT 96933635 T AT96933635 T AT 96933635T AT 96933635 T AT96933635 T AT 96933635T AT E214930 T1 ATE214930 T1 AT E214930T1
- Authority
- AT
- Austria
- Prior art keywords
- oral administration
- antibacterial agent
- antibacterial
- agent
- oral
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26584795 | 1995-10-13 | ||
| PCT/JP1996/002967 WO1997013516A1 (en) | 1995-10-13 | 1996-10-14 | Antibacterial composition for oral administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE214930T1 true ATE214930T1 (de) | 2002-04-15 |
Family
ID=17422903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96933635T ATE214930T1 (de) | 1995-10-13 | 1996-10-14 | Antibakterielles mittel zur oralen verabreichung |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5958915A (de) |
| EP (1) | EP0862915B1 (de) |
| KR (1) | KR100311576B1 (de) |
| CN (1) | CN1102046C (de) |
| AR (1) | AR004014A1 (de) |
| AT (1) | ATE214930T1 (de) |
| BR (1) | BR9610836A (de) |
| CA (1) | CA2234426C (de) |
| DE (1) | DE69620220T2 (de) |
| ES (1) | ES2174109T3 (de) |
| HU (1) | HU224922B1 (de) |
| MX (1) | MX9802849A (de) |
| PT (1) | PT862915E (de) |
| TW (1) | TW458778B (de) |
| WO (1) | WO1997013516A1 (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1051978B1 (de) * | 1998-01-07 | 2012-08-22 | Meiji Seika Pharma Co., Ltd. | Kristallographisch stabile amorphe cephalosporin zusammensetzungen und verfahren zu ihrer herstellung |
| DK1126826T6 (en) * | 1998-11-02 | 2019-06-24 | Alkermes Pharma Ireland Ltd | Multiparticulate modified release of methylphenidate |
| US20080113025A1 (en) * | 1998-11-02 | 2008-05-15 | Elan Pharma International Limited | Compositions comprising nanoparticulate naproxen and controlled release hydrocodone |
| JP6154758B2 (ja) * | 2000-11-21 | 2017-06-28 | 杏林製薬株式会社 | ドライシロップ剤 |
| US7125565B2 (en) * | 2000-12-01 | 2006-10-24 | Kyowa Hakko Kogyo Co., Ltd. | Composition improved in the solubility or oral absorbability |
| JP5051865B2 (ja) | 2001-05-29 | 2012-10-17 | タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド | レシチンでのプロドラッグエステル非乳化調合物の経口バイオアベイラビリティの向上 |
| US20030060451A1 (en) * | 2001-05-29 | 2003-03-27 | Rajneesh Taneja | Enhancement of oral bioavailability of non-emulsified formulations of prodrug esters with lecithin |
| WO2003097102A1 (fr) * | 2002-05-22 | 2003-11-27 | Shionogi & Co., Ltd. | Preparation pharmaceutique dans laquelle la propriete de dissolution d'un medicament faiblement soluble dans l'eau est amelioree |
| AUPS303202A0 (en) * | 2002-06-20 | 2002-07-11 | Pacific Biolink Pty Limited | Protein based oral lubricant |
| EP1555024B1 (de) | 2002-10-02 | 2010-09-29 | Meiji Seika Kaisha Ltd. | Antibakterielle medizinische zusammensetzung mit erhöhtem oralem absorptionsvermögen |
| KR101178657B1 (ko) * | 2003-10-08 | 2012-08-30 | 메이지 세이카 파루마 가부시키가이샤 | 세프디토렌 피복실을 함유하는 비결정질 항균 조성물 |
| JP2005162696A (ja) * | 2003-12-04 | 2005-06-23 | Nichiko Pharmaceutical Co Ltd | 溶出性に優れたセフジトレンピボキシル製剤 |
| CN101115459B (zh) | 2004-11-16 | 2012-03-21 | 3M创新有限公司 | 包括含磷表面处理的牙科填料 |
| CN101098673B (zh) | 2004-11-16 | 2012-02-29 | 3M创新有限公司 | 包括磷酸盐的牙科填料和组合物 |
| CN101102741B (zh) | 2004-11-16 | 2012-05-02 | 3M创新有限公司 | 具有释放钙和磷的玻璃的牙科组合物 |
| CA2587278A1 (en) * | 2004-11-16 | 2006-05-26 | 3M Innovative Properties Company | Dental fillers, methods, compositions including a caseinate |
| EP1954253A4 (de) | 2005-06-08 | 2011-07-27 | Elan Pharma Int Ltd | Nanoteilchenförmige und kontrolliert freigesetzte zusammensetzungen mit cefditoren |
| US20080069879A1 (en) * | 2006-05-02 | 2008-03-20 | Ravishekhar Bhiwgade | Stable solid dosage form containing amorphous cefditoren pivoxil and process for preparation thereof |
| WO2010068359A1 (en) | 2008-12-11 | 2010-06-17 | 3M Innovative Properties Company | Surface-treated calcium phosphate particles suitable for oral care and dental compositions |
| TR201000688A2 (tr) * | 2010-01-29 | 2011-08-22 | B�Lg�� Mahmut | Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar. |
| US20130143857A1 (en) * | 2010-07-23 | 2013-06-06 | Lupin Limited | Pharmaceutical compositions of cefditoren pivoxil |
| WO2016114727A1 (en) | 2015-01-16 | 2016-07-21 | Öğün Yusuf Toktamiş | Cefditoren pivoxil compositions with improved stability and production methods thereof |
| CN105663058A (zh) * | 2016-02-01 | 2016-06-15 | 济南康和医药科技有限公司 | 一种头孢妥仑匹酯纳米粒药物制剂及制备方法 |
| GB202306826D0 (en) | 2023-05-09 | 2023-06-21 | Adjutec Pharma As | Therapy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5936609A (ja) * | 1982-08-26 | 1984-02-28 | Nitto Electric Ind Co Ltd | 粘着性貼付製剤 |
| JPS59184122A (ja) * | 1983-03-31 | 1984-10-19 | Nitto Electric Ind Co Ltd | アクリル系膏体 |
| JPS60102168A (ja) * | 1983-11-08 | 1985-06-06 | Tsukishima Shokuhin Kogyo Kk | エイコサペンタエン酸強化乳化物及び食品の製造方法 |
| IE58487B1 (en) * | 1984-09-07 | 1993-09-22 | Kaisha Maiji Seika | New cephalosporin compounds and the production thereof |
| JPH0678234B2 (ja) * | 1988-04-19 | 1994-10-05 | 明治製菓株式会社 | 経口投与用抗菌組成物 |
| JPH0635394B2 (ja) * | 1989-02-28 | 1994-05-11 | 雪印乳業株式会社 | 薬物の溶解性および吸収性の改善方法 |
| JPH0717866A (ja) * | 1993-06-16 | 1995-01-20 | Meiji Seika Kaisha Ltd | 医薬組成物 |
| JPH0840907A (ja) * | 1994-08-03 | 1996-02-13 | Meiji Seika Kaisha Ltd | セファロスポリン注射剤 |
-
1996
- 1996-10-11 AR ARP960104719A patent/AR004014A1/es active IP Right Grant
- 1996-10-14 KR KR1019980702618A patent/KR100311576B1/ko not_active Expired - Lifetime
- 1996-10-14 AT AT96933635T patent/ATE214930T1/de not_active IP Right Cessation
- 1996-10-14 DE DE69620220T patent/DE69620220T2/de not_active Expired - Fee Related
- 1996-10-14 CN CN96198295A patent/CN1102046C/zh not_active Expired - Lifetime
- 1996-10-14 ES ES96933635T patent/ES2174109T3/es not_active Expired - Lifetime
- 1996-10-14 BR BR9610836A patent/BR9610836A/pt not_active IP Right Cessation
- 1996-10-14 EP EP96933635A patent/EP0862915B1/de not_active Expired - Lifetime
- 1996-10-14 WO PCT/JP1996/002967 patent/WO1997013516A1/ja not_active Ceased
- 1996-10-14 PT PT96933635T patent/PT862915E/pt unknown
- 1996-10-14 US US09/051,318 patent/US5958915A/en not_active Expired - Lifetime
- 1996-10-14 CA CA002234426A patent/CA2234426C/en not_active Expired - Lifetime
- 1996-10-14 HU HU9900609A patent/HU224922B1/hu unknown
- 1996-10-22 TW TW085112901A patent/TW458778B/zh not_active IP Right Cessation
-
1998
- 1998-04-13 MX MX9802849A patent/MX9802849A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR004014A1 (es) | 1998-09-30 |
| KR19990064137A (ko) | 1999-07-26 |
| DE69620220D1 (de) | 2002-05-02 |
| DE69620220T2 (de) | 2002-11-28 |
| EP0862915A1 (de) | 1998-09-09 |
| KR100311576B1 (ko) | 2001-12-28 |
| ES2174109T3 (es) | 2002-11-01 |
| HUP9900609A3 (en) | 2001-04-28 |
| CN1102046C (zh) | 2003-02-26 |
| CA2234426A1 (en) | 1997-04-17 |
| TW458778B (en) | 2001-10-11 |
| HU224922B1 (en) | 2006-04-28 |
| CA2234426C (en) | 2003-07-08 |
| WO1997013516A1 (en) | 1997-04-17 |
| HUP9900609A2 (hu) | 1999-07-28 |
| EP0862915B1 (de) | 2002-03-27 |
| HK1016477A1 (en) | 1999-11-05 |
| CN1202110A (zh) | 1998-12-16 |
| PT862915E (pt) | 2002-09-30 |
| EP0862915A4 (de) | 1998-11-11 |
| BR9610836A (pt) | 1999-07-13 |
| MX9802849A (es) | 1998-11-30 |
| US5958915A (en) | 1999-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE214930T1 (de) | Antibakterielles mittel zur oralen verabreichung | |
| ATE206924T1 (de) | Oral anzuwendende arzneizubereitung enthaltend olanzapin | |
| DE69635993T8 (de) | Gelierte arzneimittel zur oralen verabreichung | |
| DK0936913T4 (da) | Oralt farmaceutisk præparat indeholdende ibandronat | |
| DE10199046I2 (de) | Rapamycin-Zubereitungen zur oralen Verabreichung | |
| DK0754061T3 (da) | Ny oral farmaceutisk doseringsform | |
| BR9610153A (pt) | Formulações farmacêuticas | |
| BR9611626A (pt) | Formulações farmacéuticas | |
| NO954486D0 (no) | Farmasöytiske formuleringsgrunnlag | |
| FI951316L (fi) | Peroraalinen formulaatio | |
| DE69807768D1 (de) | Rapamycin enthaltende Formulierungen zur oralen Verabreichung | |
| DE69827947T2 (de) | Rapamycin-formulierungen zur oralen verabreichung | |
| FI973280L (fi) | Farmaseuttinen koostumus | |
| FI973230L (fi) | Uusi farmaseuttinen formulaatio | |
| BR9605777A (pt) | Composição farmacêutica | |
| BR9605131A (pt) | Composição farmacêutica | |
| ATE239508T1 (de) | Partikulare arzneiform | |
| SE9502453D0 (sv) | Drug formulations | |
| KR970015941U (ko) | 구두골 | |
| BR7501191U (pt) | Conjunto de hastilhas para escova dental | |
| SE9404467D0 (sv) | Drug formulations | |
| SE9402925D0 (sv) | Novel oral pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |